Department of Imaging NHS Forth Valley, Larbert, UK.
Department of Imaging NHS Greater Glasgow and Clyde, Glasgow, UK.
Br J Radiol. 2022 May 1;95(1133):20211241. doi: 10.1259/bjr.20211241. Epub 2022 Feb 24.
The purpose of this article is to review the technical and radiological aspects of MagSeed localisation, to assess its accuracy based on post-localisation mammograms and excision specimen X-rays and to discuss the radiological experience of our institutions.
Two-year data were collected retrospectively from three NHS boards from the West of Scotland. A total of 309 MagSeeds were inserted under mammographic or ultrasonographic guidance in 300 women with unifocal, multifocal and/or bilateral breast lesions at the day of surgery or up to 30 days prior to it. Radiological review of post-localisation mammograms and intraoperative specimen X-rays as well as a review of the surgical outcomes were performed to assess the accuracy and efficacy of the method. Our experience relating to the technique's strengths and downsides were also noted.
The MagSeeds were inserted on average 7.2 days before surgery. The localisation technique was straight forward for the radiologists. In 99% of the cases, the MagSeed was successfully deployed and 100% of the successfully localised lesions were excised at surgery. There was no difference in the accuracy of the localisation whether this was mammographically or ultrasonographically guided. On post-localisation mammograms, the MagSeed was radiologically accurately positioned in 97.3% of the cases. No delayed MagSeed migration was observed. On the specimen X-rays, the lesion was centrally positioned in 45.1%, eccentric within more than 1 mm from the margin in 35.7% and in 14.8% it was at the specimen's margin. The re-excision rate was 18.3%.
The MagSeed is an accurate and reliable localisation method in breast conserving surgery with good surgical outcomes.
To our knowledge, the radiological aspects of MagSeed localisation have not been widely described in peer-reviewed journals thus far.
本文旨在回顾 MagSeed 定位的技术和影像学方面,根据定位后的乳房 X 光片和切除标本 X 光片评估其准确性,并讨论我们机构的放射学经验。
从苏格兰西部的三个 NHS 委员会回顾性收集了两年的数据。在手术当天或之前 30 天内,共有 300 名患有单发、多发和/或双侧乳房病变的女性在乳房 X 线或超声引导下共插入 309 个 MagSeed。对定位后的乳房 X 光片和术中标本 X 光片进行影像学复查,并对手术结果进行复查,以评估该方法的准确性和有效性。我们还注意到与该技术优缺点相关的经验。
MagSeed 平均在手术前 7.2 天插入。放射科医生对定位技术的操作简单。在 99%的情况下,MagSeed 成功部署,100%的成功定位病变在手术中被切除。无论采用乳房 X 线还是超声引导,定位的准确性均无差异。在定位后的乳房 X 光片中,MagSeed 在 97.3%的情况下放射学上定位准确。未观察到延迟的 MagSeed 迁移。在标本 X 光片中,病变中心位于 45.1%,偏心距离超过 1 毫米的边缘 35.7%,位于标本边缘的 14.8%。再次切除率为 18.3%。
MagSeed 是保乳手术中一种准确可靠的定位方法,具有良好的手术效果。
据我们所知,MagSeed 定位的放射学方面迄今为止尚未在同行评议的期刊上广泛描述。